Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postmenopausal Women With Early Hormone-Receptor Positive Breast Cancer/no Metastasis

NCT00638391 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00638391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00638391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postmenopausal Women With Early Hormone-Receptor Positive Breast Cancer/no Metastasis
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 31, 2005
Completion date
March 31, 2007
Enrollment
1,600 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer